-
Analysis of China's chemical API market prospects
API is the most basic link in the pharmaceutical industry chain and an important substance in pharmaceutical production. The quality of raw materials ...
2020-10-12 14:21 -
Mask mandates shown to significantly reduce spread of COVID-19
A new study by Simon Fraser University (SFU) researchers has found clear evidence that wearing a mask can have a significant impact on the spread of C...
2020-10-09 18:02 -
Protective antibodies persist for months in survivors of serious COVID-19 infect
People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Ma...
2020-10-09 18:00 -
Internet's role in safeguarding livelihoods during pandemic hailed
China's internet industry has helped curb the spread of COVID-19 and also improved people's lives through the development of the digital economy and d...
2020-09-30 17:40 -
J&J advances COVID-19 vaccine into phase 3 testing
News comes after last week's announcement from Novavax on its launch of a UK-based phase 3 trial
2020-09-30 17:39 -
India's chemical imports to China surge while API drops slightly
Since April, India has imported more refined oil, handicrafts, medical and scientific instruments, agrochemicals and other chemicals from China. The ...
2020-09-29 17:00 -
Metformin has a new effect? May prevent dementia
The paper showed that the hypoglycemic drug metformin may benefit patients with esophageal squamous cell carcinoma by improving the immune microenviro...
2020-09-29 14:49 -
The price of some original medicines fell, while the price of tebuconazole rose
40% Diquat will be reduced by RMB 1,000 per ton to RMB 31,000 per ton 97% Cyhalofop-butyl reduced by 5000 yuan per ton to 145000 CNY/ton 95% Fenoxap...
2020-09-29 11:35 -
Adequate vitamin D levels may reduce complications and death in COVID-19 patient
COVID-19 patients hospitalized with adequate vitamin D and blood levels of 25-hydroxyvitamin D of at least 30 ng / mL
2020-09-28 16:33 -
Gilead and MSD recently made 2 consecutive ADC-heavy deals
Recently, two consecutive heavyweight ADC drug deals have focused attention back on the antibody-coupled drug space.
2020-09-27 16:21
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products